Aveh Sina Pharmaceutical Company (DAVE) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DAVE
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 4,481,704 | 1,949,650 | 1,428,641 | 686,592 | 499,523 | 438,612 |
| Cost of operating revenue | -2,150,736 | -1,328,604 | -978,341 | -434,955 | -275,904 | -310,660 |
| Gross profit (loss) | 2,330,968 | 621,046 | 450,300 | 251,637 | 223,619 | 127,952 |
| Selling, general and administrative expenses | -445,933 | -203,035 | -228,228 | -110,558 | -70,408 | -60,562 |
| Operating profit (loss) | 1,885,035 | 412,243 | 222,474 | 141,525 | 153,652 | 68,824 |
| Finance costs | -86,956 | -48,124 | -51,749 | -46,503 | -40,563 | -25,831 |
| Other non-operating income and expenses | 207,435 | 3,368 | 54 | 15,490 | 2,148 | 1,453 |
| Profit (loss) from continuing operations before tax | 2,005,514 | 367,487 | 170,779 | 110,512 | 115,237 | 44,446 |
| Current year tax | -501,379 | -66,148 | -27,666 | -24,865 | -20,056 | -9,730 |
| Net profit (loss) from continuing operations | 1,504,135 | 301,339 | 143,113 | 85,647 | 95,181 | 34,716 |
| Net profit (loss) | 1,504,135 | 301,339 | 143,113 | 85,647 | 95,181 | 34,716 |
| Basic earnings (loss) per share | 716 rials | 201 rials | 143 rials | 123 rials | 136 rials | 72 rials |
| Net earnings (loss) per share, rials | 717 rials | 201 rials | 144 rials | 124 rials | 137 rials | 73 rials |
| Capital | 2,100,000 | 1,500,000 | 1,000,000 | 696,000 | 696,000 | 480,000 |
Reporting periods
49 periods are on file for this report, from the period ending 1395/12/30 to the period ending 1405/06/31.